Brief: Clover Biopharmaceuticals Says Shares Will Be Included In Hang Seng Composite Index From March 7
24/02/2022 10:44
Feb 24 (Reuters) - Clover Biopharmaceuticals Ltd 2197.HK :
* SHARES WILL BE INCLUDED AS A CONSTITUENT STOCK OF HANG
SENG
COMPOSITE INDEX FROM MARCH 7
Further company coverage: 2197.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clover Biopharmaceuticals
See all newsChina's Clover Biopharma H1 revenue drops sharply, flags going-concern doubt
Brief: Clover Biopharmaceuticals Posts FY Loss Of RMB205.1 MLN
Brief: Clover Announces Positive Phase I Clinical Data For Rsv-Hmpv-Piv3 Combination Vaccines And For Rsv Re-Vaccination In Older Adults
Brief: Clover Biopharmaceuticals Posts H1 Revenue Of RMB3.3 Million
Brief: Clover Biopharmaceuticals Says It Terminates Cooperation With Adimmune